High Dose Oral Tolerance in Ovalbumin TCR-Transgenic Mice: Systemic Neutralization of IL-12 Augments TGF-β Secretion and T Cell Apoptosis

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2348-2357

  Marth, Thomas ^a   Strober, Warren ^a   Kelsall, Brian L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 12; LYMPHOCYTE ANTIGEN RECEPTOR; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; DOSE RESPONSE; DRUG ANTAGONISM; FEMALE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; PEYER PATCH; SECRETION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; FEMALE; IMMUNE TOLERANCE; INJECTIONS, INTRAVENOUS; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; PEYER'S PATCHES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030587132     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Mowat, A. M. 1994. Oral tolerance and regulation of immunity to dietary antigens.. In Handbook of Mucosal Immunology. P. L. Ogra, J. R. McGhee, J. Mestecky, W. Strober, and J. Bienenstock, eds. Academic Press, San Diego, pp. 185-201.
2. Weiner, H. L., A. Friedman, A. Miller, S. J. Khoury, A. Al-Sabbagh, L. Santos, M. Sayegh, R. B. Nussenblatt, D. E. Trentham, and D. A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
3. Nagler-Anderson, C., L. A. Bober, M. E. Robinson, G. W. Siskind, and G. J. Thorbecke. 1986. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II antigen. Proc. Natl. Acad. Sci. USA 83:7443.
4. Whilacre, C. C., I. E. Gienapp, C. G. Orosz, and D. M Bitar. 1991. Oral tolerance in experimental autoimmune encephalitis. III. Evidence for clonal anergy. J. Immunol. 147:2155.
5. Higgins, P. J., and H. L. Weiner. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:440.
6. Nussenblatt, R. B., R. R. Caspi, R. Mahdi, C.-C. Chan, F. Roberge, O. Lider, and H. L. Weiner. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144:1689.
7. Weiner, H. L., G. A. Mackin, M. Matsui, E. J. Orav, S. J. Khoury, D. M. Dawson, and D. A. Hafler. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321.
8. Trentham, D. E., R. A. Dynesius-Trentham, E. J. Orav, D. Combitchi, C. Lorenzo, K. L. Sewell, D. A. Hafler, and H. L. Weiner. 1993. Effects of oral administration of collagen on rheumatoid arthritis. Science 261:1727.
9. Friedman, A., and H. L. Weiner. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91:6688.
10. Chen, Y., J.-I. Inobe, R. Marks, P. Gonella, V. K. Kuchroo, and H. L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
11. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
12. + cells mediate active suppression. J. Immunol. 155:910.
13. Miller, A., O. Lider, A. B. Roberts, M. B. Sporn, and H. L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89:421.
14. Chen, Y., V. K. Kuchroo, J.-I. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalitis. Science 265:1237.
15. Miller, A., O. Lider, and H. L. Weiner. 1991. Antigen-driven bystander suppression after oral administration of antigen. J. Exp. Med. 174:791.
16. Santos, L. M. B., A. Al-Sabbagh, A. Londono, and H. L. Weiner. 1994. Oral tolerance to myelin basic protein induces regulatory TGF-β secreting cells in Peyer's patches of SJL mice. Cell. Immunol. 157:439.
17. lo thymocytes in vivo. Science 250: 1720.
18. Crowley, M. K., M. Inaba, M. Wittmer-Pack, and R. M. Steinman. 1989. The surface of mouse dendritic cells: FACS analysis of dendritic cells from different tissues including thymus. Cell. Immunol 118:108.
19. Flaumenhaft, R., S. Kojima, M. Abe, and D. B. Rifkin. 1993. Activation of latent transforming growth factor β. Adv. Pharmacol. 24:51.
20. Haskins, K., R. Kubo, J. White, M. Pigeon, J. Kappler, and P. Marrack. 1983. The major histocompatility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157:1149.
21. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
22. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakolew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
23. Kelsall, B. L., R. O. Ehrhardt, and W. Strober. 1994. Induction of a primary interferon-γ response by Peyer's patch dendritic cells is mediated by IL-12 and inhibited by IL-4. FASEB J. 8:A207 (Abstr.).
24. + T cells that secrete IFN-γ and IL-5. J. Immunol. 145:68.
25. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera iosn as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309.
26. Wilson, D. A., M. Bailey, N. A. Williams, and C. R. Stokes. 1991. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur. J. Immmol. 21:2333.
27. Vajdy, M., and N. Lycke. 1993. Stimulation of antien-specitic T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant. Immunology 80:197.
28. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specitic T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
29. Kelsall, B. L., and W. Strober. 1995. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J. Exp. Med. 183:237.
30. Phillips-Quagliata, J. M., and M. E. Lamm. 1994. Lymphocyte homing to mucosal effector sites. In. Handbook of Mucosal Immunology. P. L. Ogra, J. R. McGhee, J. Mestecky, W. Strober, and J. Bienenstock, eds. Academic Press, San Diego, pp. 225-239.
31. Rocha, B., A. Grandien, and A. A. Freitas. 1995. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J. Exp. Med. 181:993.
32. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24:793.
33. Barral-Netto, M., A. Barral, C. E. Brownell, Y. A. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257:545.
34. Clerici, M., A. Sarin, R. L. Coffman, T. A. Wynn, S. P. Blatt, C. W. Hendrix, S. F. Wolf, G. M. Shearer, and P. A. Henkart. 1994. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. USA 91:11811.
35. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
36. Weller, M., D. B. Constam, U. Malipiero, and A. Fontana. 1994. Transforming growth factor-β2 induces apoptosis in murine T cell clones without down-regulating bcl-2 mRNA expression. Eur. J. Immunol. 24:1293.
37. Ramsdell, F., M. S. Seaman, R. E. Miller, K. S. Picha, M. K. Kennedy, and D. H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545.
38. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stüber, and W. Strober. 1995. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1281.
39. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med 181:381.